Recent U.S. Patent Decisions and Their Significance to Chinese Companies Electrical & Mechanical Engineering Patent Conference Shenzhen, China October.
Recent Developments In Parties Obligations In Hatch-Waxman Act Litigation Brian V. Slater Presented at American Conference Institutes Maximizing Pharmaceutical.
Www.fitzpatrickcella.com Compliance with the Written Description Requirement FITZPATRICK, CELLA, HARPER & SCINTO 30 Rockefeller Plaza New York, NY Raymond.
Www.fitzpatrickcella.com Use of Prior Statements, Depositions and Corollary Proceedings: Searing Impeachment and Effective Rehabilitation FITZPATRICK,
FITZPATRICK, CELLA, HARPER & SCINTO © 2008 | 1 Brand v. Miller: Standard of Review of Factual Findings Made by the PTO Board.
The Opinion Of Counsel As Defense To Willful Infringement Robert L. Baechtold, Esq. FITZPATRICK, CELLA, HARPER & SCINTO 30 Rockefeller Plaza New York,
Www.fitzpatrickcella.com Recent Developments In Patent Law: Update On Federal Circuit Cases FITZPATRICK, CELLA, HARPER & SCINTO 30 Rockefeller Plaza New.
Post Grant Challenges: Strategy and Considerations after the America Invents Act of 2011 IP Law & Management Institute November 7, 2011 Justin J. Oliver.
Inequitable Conduct: Getting to Therasense and Beyond John D. Murnane October 18, 2012 Melinda R. Roberts.
The Combined Impact of Prior Art Obviousness and Obviousness-Type Double Patenting on Pharmaceutical Patent Life Cycle Strategies Brian V. Slater ACI 12.
Charles P. Baker
FITZPATRICK, CELLA, HARPER & SCINTO © 2008 | 1 Obviousness Under 35 U.S.C. §103 in the United States Bruce C. Haas, Esq.
